封面
市场调查报告书
商品编码
1373832

全球兽用抗生剂和抗菌药物市场 - 市场规模、份额、成长分析:按类型、按应用分类 - 产业预测(2023-2030)

Global Animal Antibiotics and Antimicrobials Market Size, Share, Growth Analysis, By Type(Penicillins, Tetracyclines), By Application(Veterinary Hospitals & Clinics, Veterinary Pharmacies) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2021年全球兽用抗生剂和抗菌剂市场规模为43.2亿美元,2022年为44.7亿美元。预计该市场在预测期(2023-2030年)将以3.5%的年复合成长率成长,到2030年将达到58.9亿美元。

全球兽用抗生剂和抗菌药物市场是兽药产业的重要组成部分,旨在促进动物健康和福利。全球兽用抗生剂和抗菌剂市场的主要驱动因素之一是对动物性蛋白质的需求不断增长。随着世界人口的成长和可支配所得的增加,肉、乳和蛋的消费量显着增加。因此,畜牧业生产不断扩大,对预防和治疗动物感染疾病的抗生素和抗菌药物的需求增加。市场成长的另一个因素是动物疾病的日益普及。呼吸道感染疾病、胃肠道感染疾病和乳腺炎等感染疾病对动物健康和生产力构成重大威胁。抗生素和抗菌剂在控制和管理这些疾病方面发挥重要作用,刺激了市场需求。此外,人们越来越关注动物福利和减少动物到人类的疾病传播。抗生素和抗菌药物对于维持动物健康和福利以及确保最佳生长和生产力至关重要。

禽流感、口蹄疫、猪瘟等动物感染疾病的爆发凸显了使用抗生素和抗菌药物来控制和预防疾病传播的必要性。与疾病爆发相关的潜在经济损失正在推动对这些产品的需求,特别是在此类疾病流行率较高的地区。这项需求是由保护牲畜健康和维持牲畜生产力的需要所驱动的。

消费者偏好以及食品安全和永续性意识的增强正在增加对不含抗生素的动物产品的需求。消费行为的这些变化促使生产者采用无抗生素生产系统,对兽用抗生素和抗菌药物的需求产生负面影响。生产者正在透过探索动物疾病预防和促进生长的替代方法来满足消费者的期望并符合市场趋势,重点是永续性和减少抗生素的使用。我正在努力。

本报告研究了全球兽用抗生剂和抗菌药物市场,提供了市场概况,包括按类型、应用、地区和参与市场的公司概况分類的趋势。

目录

执行摘要

母市场分析

市场规模

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

关键市场洞察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 趋势分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
  • 法规状况
  • 波特的分析

全球兽用抗生剂和抗菌剂市场(按类型)

  • 市场概况
  • 青霉素
  • 四环素类
  • 磺酰胺
  • 大环内酯系列
  • Aminoglycosides
  • 氟喹诺酮类及其他

全球兽用抗生剂和抗菌剂市场(按应用)

  • 市场概况
  • 动物医院、诊所
  • 动物药房
  • 网路药房

全球兽用抗生剂和抗菌剂市场(按地区)

  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

竞争形势

  • 主要企业简介
    • Zoetis Inc.
    • Merck Animal Health
    • Elanco Animal Health
    • Boehringer Ingelheim Animal Health
    • Ceva Sante Animale
    • Vetoquinol SA
    • Bayer Animal Health
    • Virbac
    • Dechra Pharmaceuticals
    • Norbrook Laboratories Ltd.
    • Huvepharma
    • Phibro Animal Health Corporation
    • China Animal Husbandry Co., Ltd.
    • Hester Biosciences Limited
    • Indian Immunologicals Ltd.
    • Hipra
    • Bimeda Holdings Plc
    • Kyoritsu Seiyaku Corporation
    • Vetoquinol
    • Ouro Fino Saude Animal
简介目录
Product Code: SQMIG35A2329

Global Animal Antibiotics and Antimicrobials Market size was valued at USD 4.32 billion in 2021 and is poised to grow from USD 4.47 billion in 2022 to USD 5.89 billion by 2030, growing at a CAGR of 3.5% in the forecast period (2023-2030).

The global animal antibiotics and antimicrobials market is a vital component of the veterinary pharmaceutical industry, aimed at promoting animal health and welfare. One of the primary drivers of the global animal antibiotics and antimicrobials market is the increasing demand for animal protein. With the growing global population and rising disposable incomes, there has been a significant rise in the consumption of meat, milk, and eggs. This has led to the expansion of livestock production, thereby driving the need for antibiotics and antimicrobials to prevent and treat infectious diseases in animals. Another factor contributing to market growth is the rising prevalence of animal diseases. Infectious diseases, such as respiratory infections, gastrointestinal infections, and mastitis, pose a significant threat to animal health and productivity. Antibiotics and antimicrobials play a crucial role in controlling and managing these diseases, thus fueling the demand in the market. Moreover, there is an increasing focus on animal welfare and the reduction of disease transmission from animals to humans. Antibiotics and antimicrobials are essential in maintaining the health and well-being of animals, ensuring their optimal growth and productivity.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Antibiotics And Antimicrobials Market Segmental Analysis

The global animal antibiotics and antimicrobials market is segmented based on type, application, and region. Based on type, the market can be segmented into Penicillins, Tetracyclines, Sulfonamides, Macrolides, Aminoglycosides, Fluoroquinolones, and Others. Based on application, the market is segmented into Veterinary Hospitals & Clinics, Veterinary Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Animal Antibiotics And Antimicrobials Market Dynamics

Drivers of the Global Animal Antibiotics And Antimicrobials Market

Disease Outbreaks and Epidemics

The occurrence of infectious diseases among animals, such as avian influenza, foot-and-mouth disease, and swine fever, underscores the necessity of using antibiotics and antimicrobials to control and prevent the spread of diseases. The potential economic losses associated with disease outbreaks drive the demand for these products, particularly in regions where the prevalence of such diseases is high. This demand stems from the need to protect animal health and maintain productivity within the livestock industry.

Restraints in the Global Animal Antibiotics And Antimicrobials Market

Consumer Preference for Antibiotic-Free Products

Evolving consumer preferences and a heightened awareness regarding food safety and sustainability have resulted in an increased demand for antibiotic-free animal products. This shift in consumer behaviour has motivated producers to adopt antibiotic-free production systems, which in turn has had a negative impact on the demand for animal antibiotics and antimicrobials. Producers are striving to meet consumer expectations and align with market trends by exploring alternative approaches to disease prevention and growth promotion in animals, with a focus on sustainability and reduced antibiotic usage.

Market Trends for Global Animal Antibiotics And Antimicrobials Key

Growing Emphasis on Antibiotic Alternatives and Responsible Use of Antimicrobials. With the rising concerns over antimicrobial resistance (AMR) and its impact on human and animal health, there is a shift towards reducing the use of antibiotics in animal production. This trend is driven by regulatory initiatives, consumer awareness, and a push from industry stakeholders to find effective alternatives that promote animal health while minimising the risk of AMR. Antibiotic alternatives such as probiotics, prebiotics, phytogenics, and vaccines are gaining traction as viable options to maintain animal health and improve performance.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Animal Antibiotics and Antimicrobials Market by Type
    • Market Overview
    • Penicillins
    • Tetracyclines
    • Sulfonamides
    • Macrolides
    • Aminoglycosides
    • Fluoroquinolones and Others.
  • Global Animal Antibiotics and Antimicrobials Market by Application
    • Market Overview
    • Veterinary Hospitals & Clinics
    • Veterinary Pharmacies
    • Online Pharmacies and Others.
  • Global Animal Antibiotics and Antimicrobials Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Zoetis Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck Animal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Elanco Animal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boehringer Ingelheim Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vetoquinol S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Dechra Pharmaceuticals (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Norbrook Laboratories Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Phibro Animal Health Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • China Animal Husbandry Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Hester Biosciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Indian Immunologicals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Hipra (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bimeda Holdings Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Kyoritsu Seiyaku Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vetoquinol (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ouro Fino Saude Animal (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments